Increased Risk of Parkinson's Disease Linked to Metabolic Syndrome, Study Shows
A new study links metabolic syndrome to an increased risk of Parkinson's disease. Maintaining metabolic health may help reduce the likelihood of developing neurodegenerative conditions. Source: Medical Xpress.
Recent research published in the journal Neurology has highlighted a noteworthy association between metabolic syndrome and an elevated risk of developing Parkinson's disease. The study, conducted by scientists from the Karolinska Institutet in Stockholm, examined data from over 467,200 individuals with an average age of 57, followed for a median period of 15 years. Findings revealed that individuals with metabolic syndrome—characterized by risk factors such as excess abdominal fat, high blood pressure, elevated blood sugar, high triglycerides, and low HDL (
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Anti-Aging Effects of Psilocybin: Extending Cell Lifespan by Over 50%
Emerging research suggests that psilocybin, the compound found in magic mushrooms, may extend human cell lifespan by over 50% and support healthy aging, opening new avenues for anti-aging therapies.
England Launches Pioneering Gonorrhea Vaccination Program to Combat Rising Cases
England has launched the world's first routine gonorrhea vaccination program in response to rising cases and antibiotic resistance, aiming to reduce infections significantly.
AI-Driven Models Enhance Prediction of In-Hospital Mortality for ICU Cancer Patients
Machine learning models, including the CatBoost classifier, show high accuracy in predicting in-hospital mortality among ICU patients with lymphoma, offering valuable insights for personalized risk assessment.
Researchers Develop Over 400 Unique Types of Nerve Cells for Neurological Studies
Scientists at ETH Zurich have successfully produced over 400 different types of nerve cells in the lab, paving the way for advanced neurological research and personalized treatments for brain disorders.